Summit Therapeutics Inc. Income Taxes Paid
Summit Therapeutics Inc. (SMMT) reported Income Taxes Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-23
- Summit Therapeutics Inc. income taxes paid, net for the quarter ending 2024-12-31 was $0.00.
- Summit Therapeutics Inc. income taxes paid, net for the quarter ending 2024-09-30 was $0.00.
- Summit Therapeutics Inc. income taxes paid, net for the quarter ending 2023-12-31 was $0.00.
- Summit Therapeutics Inc. income taxes paid, net for the quarter ending 2023-09-30 was $0.00.
- Summit Therapeutics Inc. income taxes paid, net for fiscal 2025 was $0.00.
- Summit Therapeutics Inc. income taxes paid, net for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Summit Therapeutics Inc. income taxes paid, net for fiscal 2023 was $52.00K.
- Summit Therapeutics Inc. income taxes paid, net for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 11 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $52.00K 10-K · filed 2026-02-23 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $52.00K 10-Q · filed 2024-10-30 | ||||
| 2023-06-30 | $52.00K 10-Q · filed 2024-08-06 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $0.00 derived: sum of 2 quarters · filed 2025-02-24 | $0.00 10-K · filed 2025-02-24 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | |||||
| 2021-12-31 | $1.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-12-21 | $1.00K derived: sum of 2 quarters · filed 2022-12-21 | $7.00K derived: sum of 3 quarters · filed 2022-12-21 | $7.00K 10-K/A · filed 2022-12-21 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $6.00K derived: sum of 2 quarters · filed 2022-11-09 | $6.00K 10-Q · filed 2022-11-09 | -$73.00K derived: sum of 4 quarters · filed 2022-12-21 | ||
| 2021-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $6.00K 10-Q · filed 2022-08-11 | -$73.00K derived: sum of 3 quarters · filed 2022-12-21 | -$73.00K derived: sum of 4 quarters · filed 2022-12-21 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | -$79.00K derived: sum of 2 quarters · filed 2022-12-21 | -$79.00K derived: sum of 3 quarters · filed 2022-12-21 | -$76.00K derived: sum of 4 quarters · filed 2022-12-21 | ||
| 2020-12-31 | -$79.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-12-21 | -$79.00K derived: sum of 2 quarters · filed 2022-12-21 | -$76.00K derived: sum of 3 quarters · filed 2022-12-21 | -$70.00K 10-K/A · filed 2022-12-21 | -$70.00M 10-K · filed 2021-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.00K derived: sum of 2 quarters · filed 2021-11-15 | $9.00K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $9.00K 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $6.00K 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | $63.00K 10-K · filed 2021-03-31 | |||||
| 2019-01-31 | $72.00K 10-K · filed 2021-03-31 | |||||
| 2018-01-31 | $554.00K 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |